Advocacy intelligence hub — real-time data for patient organizations
GlaxoSmithKline — PHASE3
Roswell Park Cancer Institute — PHASE1
Heba Ahmed Mohamed
Aristotle University Of Thessaloniki — NA
Gustave Roussy, Cancer Campus, Grand Paris — PHASE2
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — PHASE2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Novita Pharmaceuticals, Inc. — PHASE2, PHASE3
University of California, Irvine — PHASE2
Nanjing Leads Biolabs Co.,Ltd — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Matthew Krebs, Dr
The Christie Hospital
Lilian T Gien
ECOG-ACRIN Cancer Research Group
John D. Hainsworth, MD, MD
SCRI Development Innovations, LLC
📍 NASHVILLE, TN
BioNTech Responsible Person
BioNTech SE
Aung Naing
M.D. Anderson Cancer Center
Pepi Pencheva
MacroGenics